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Overview
• Mycoplasma background
• Project description
• Methods
• Results
• Future Studies
Mycoplasma
• Smallest self-replicating organisms
• Evolved from Gram-positive bacteria
• Lack a cell wall
• Minimal genomes
• Strict nutrient requirements
• Reliant on host macro-
molecules
Pathogenesis
• Colonizes mucosal surfaces 
• Important diseases:
• Atypical pneumonia (humans)
• Contagious Bovine Pleuropneumonia (cattle)
• Porcine Respiratory Disease Complex (pigs)
• Resistant toβ-lactam antibiotics
• Difficult to treat due to lack of  cell wall
• Vaccines are partially effective in production 
animals
Project Goal
Develop gene-specific mutagenesis in 
Mycoplasma hyopneumoniae to better 
understand pathogenic mechanisms that 
lead to chronic infections in pigs
Experimental Design
1. Synthesize an antibiotic marker with a promoter that will function in 
both E. coli and mycoplasmas
• Fragment also must have unique flanking sequences
• tetM and pur genes will  be used along with promoters from aac-aph
(gentamycin marker of  Tn4001) and Spirilin (Spiroplasma)
2. Generate PCR products of  the construct
• Purify, digest with nt.BspQI enzyme, ∆T, repurify
• Add gene-specific oligos, ligate, repurify to remove salts
3. Transform into E. coli 
• Antibiotic resistance requires RecA-catalyzed recombination of  
fragment into gene specified by oligos (lacZ for this project)
4. For the purposes of  this study, selection of  transformants occurred 
via tetracycline resistance and the colonies were scored for β-
galactosidase activity

Results – Experiment 1
• Designed plasmid with tetracycline resistance cassette (tetM) 
with aac-aph promoter
• PCR Result:  
• Primers were not specific enough
• Second, unexpected fragment was generated in PCR (2kb) 
and concentration was low
• Found a second site for one PCR primer in the cloning vector
• Solution:
• Redesigned PCR primer – yields were consistent and only 
one fragment was generated
Experiment 2 
• Generated fragment, added oligos and exogenous RecA
protein; transformed mixture directly into RecA+ and 
RecA- E. coli strains using electroporation
• Result: 
• Repeatedly arced
• Reason: high salt concentration in RecA buffer
• Solution:
• Transform the strains using CaCl2 competent cells
• Selected for tetracycline resistant colonies 
• Screened for β-galactosidase activity
• CaCl2 transformation results – TetR colonies 
with both Rec+ and Rec- cells with RecA
protein added exogenously
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Experiment 3 
• Repeat Exp 2 but with 
phosphorylated oligos, added ligase, 
purified product
• Transformed into Χ289 (recA+)
• Results:
• Successful transformation
• Slow growing colonies 
• Low β-galactosidase activity with TetR

Future Studies
• Does M. hyopneumoniae have 
recombination activity?
• RecA homolog should be 
functional
Future Studies (Continued)
• Test puromycin resistant determinant with 
Spiroplasma spiralin promoter in E. coli
• Prepare fragment with ligated oligos for 
transformation into M. hyopneumoniae
• Target is P97, the ciliary adhesin
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